LPL Financial
ORMP icon

LPL Financial’s Oramed Pharmaceuticals ORMP Stock Holding History

LPL Financial’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,185
Closed -$37.6K – 6117
2025
Q4 		$37.6K Sell
13,185
-400
-3% -$1.03K ﹤0.01% 5735
2025
Q3 		$35.9K Sell
13,585
-1,100
-7% -$2.43K ﹤0.01% 5677
2025
Q2 		$33K Buy
14,685
+700
+5% +$1.54K ﹤0.01% 5418
2025
Q1 		$29.9K Sell
13,985
-3,446
-20% -$7.95K ﹤0.01% 5211
2024
Q4 		$42.2K Sell
17,431
-21,250
-55% -$50.5K ﹤0.01% 5120
2024
Q3 		$94.4K Sell
38,681
-1,790
-4% -$4.36K ﹤0.01% 4902
2024
Q2 		$104K Sell
40,471
-5,130
-11% -$12.2K ﹤0.01% 4734
2024
Q1 		$133K Buy
45,601
+2,435
+6% +$6.81K ﹤0.01% 4613
2023
Q4 		$99.7K Buy
43,166
+5,950
+16% +$12.7K ﹤0.01% 4552
2023
Q3 		$97.1K Buy
37,216
+21,000
+130% +$66.1K ﹤0.01% 4425
2023
Q2 		$58.1K Buy
+16,216
New +$52K ﹤0.01% 4408
2021
Q1 		– Sell
-14,135
Closed -$60K – 4134
2020
Q4 		$60K Buy
+14,135
New +$46K ﹤0.01% 3720

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial's ORMP Position: Q1 2026 in Review

LPL Financial sold out of Oramed Pharmaceuticals (ORMP) in Q1 2026, closing a stake of 13,185 shares — an estimated $37.6K sold.

LPL Financial first reported a position in ORMP in Q4 2020 and held it in 12 quarters. The position peaked at $133K in Q1 2024. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • LPL Financial reported no remaining Oramed Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 13,185 Oramed Pharmaceuticals shares in Q1 2026, an estimated $37.6K.
  • LPL Financial first reported a position in Oramed Pharmaceuticals in Q4 2020 and held it in 12 quarters.
  • LPL Financial's Oramed Pharmaceuticals position peaked at $133K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.